Voss, E. A., Shoaibi, A. ., Lai, Y. H., Blacketer, C. ., Alshammari, T. ., Makadia, R. ., … Ryan, P. B. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
C. Reich
First name
C.
Last name
Reich
Li, X. ., Burn, E. ., Duarte-Salles, T. ., Yin, C. ., Reich, C. ., Delmestri, A. ., … Prieto-Alhambra, D. . (2022). Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. Bmj, 379, e071594. http://doi.org/10.1136/bmj-2022-071594
Burn, E. ., Li, X. ., Kostka, K. ., Stewart, H. M., Reich, C. ., Seager, S. ., … Prieto-Alhambra, D. . (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495–510. http://doi.org/10.1002/pds.5419
Matcho, A. ., Ryan, P. ., Fife, D. ., & Reich, C. . (2014). Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. http://doi.org/10.1007/s40264-014-0214-3
Lane, J. C. E., Weaver, J. ., Kostka, K. ., Duarte-Salles, T. ., Abrahao, M. T. F., Alghoul, H. ., … Prieto-Alhambra, D. . (2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771
Lane, J. C. E., Weaver, J. ., Kostka, K. ., Duarte-Salles, T. ., Abrahao, M. T. F., Alghoul, H. ., … Prieto-Alhambra, D. . (2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9